Efficacy of 13.3 mg/24 h versus 4.6 mg/24 h rivastigmine patch on activities of daily living in severe Alzheimer’s disease

Efficacy of 13.3 mg/24 h versus 4.6 mg/24 h rivastigmine patch on activities of daily living in severe Alzheimer’s disease

Objective: Investigate efficacy of 13.3 mg/24 h rivastigmine patch in patients with severe Alzheimer’s disease on Alzheimer’s Disease Cooperative Study–Activities of Daily Living Scale–Severe Impairment Version items and domains. Methods: Retrospective analysis of the 24-week, randomized, double-bli...

Full description

Bibliographic Details
Main Authors: Joseph L Micca, James E Galvin, Drew M Velting, Xiangyi Meng
Format: Article
Language:English
Published: SAGE Publishing 2014-12-01
Series:SAGE Open Medicine
Online Access:https://doi.org/10.1177/2050312114561569

Similar Items

Similar Items